Vietnam's pharmaceutical market sees major M&A deal

The deal, valued at over 5.73 trillion VND (about 220.6 million USD), underscores the increasing attractiveness of Vietnam's pharmaceutical industry to foreign investors.

The headquarters of Imexpharm in Dong Thap province. (Photo courtesy of the company)
The headquarters of Imexpharm in Dong Thap province. (Photo courtesy of the company)

Hanoi (VNS/VNA) - The Vietnamese pharmaceutical sector has recently witnessed one of its largest mergers and acquisitions (M&A) to date, with Livzon Pharmaceutical Group Inc. of China acquiring approximately 64.81% of Imexpharm Pharmaceutical Joint Stock Company (IMP).

The deal, valued at over 5.73 trillion VND (about 220.6 million USD), underscores the increasing attractiveness of Vietnam's pharmaceutical industry to foreign investors.

Livzon, through its Singapore-based subsidiary Lian SGP Holding Pte. Ltd., will purchase shares from existing stakeholders, including SK Investment Vina III Pte. Ltd., which holds a 47.69% stake, alongside smaller investors.

Once the transaction is finalised, expected within nine months, Imexpharm will become an indirect subsidiary of Livzon, with its financial results integrated into Livzon's consolidated reports.

This acquisition marks a significant divestment by SK Group, a major Korean conglomerate, reflecting a strategic restructuring of its investment portfolio in Vietnam.

Meanwhile, Livzon's decision to enter the Vietnamese market highlights its ambition to diversify revenue streams and mitigate risks associated with domestic market fluctuations.

Established in 1985 and headquartered in Zhuhai, China, Livzon is a prominent player in the pharmaceutical industry, specialising in research, development and manufacturing of various pharmaceutical products, including biopharmaceuticals and traditional Chinese medicines.

With over 9,000 employees and listings on both the Hong Kong and Shenzhen stock exchanges, Livzon possesses strong financial resources and extensive market expertise.

In recent years, Livzon has actively pursued international expansion, with foreign revenue accounting for nearly 15% of total sales in 2024. The acquisition of Imexpharm represents a strategic move to penetrate one of Southeast Asia's fastest-growing pharmaceutical markets.

Imexpharm, founded in 1977 and recognised as one of Vietnam's leading pharmaceutical companies, has established a solid reputation, particularly in the antibiotic sector, where it commands approximately 10% of the domestic market share.

The company has made significant investments in high-standard manufacturing facilities compliant with European standards (EU-GMP), which positions it well for both domestic sales and export opportunities.

In 2024, Imexpharm reported revenues of over 2.2 trillion VND, an 11% increase from the previous year, and a net profit of 320 billion VND.

The company aims for an average annual revenue growth of 15% through 2030, with plans to further expand its manufacturing capabilities, particularly in cardiovascular, diabetes and gastrointestinal treatment./.

VNA

See more

Permanent Deputy Prime Minister Nguyen Hoa Binh introduces the international financial centre's role and significance at the 15th legislature’s ongoing 9th session. (Photo: VNA)

New int’l financial centre to help turn Vietnam into important financial gateway: Deputy PM

Introducing the centre’s role and significance at the 15th legislature’s ongoing 9th session, Binh stated that it will be a diverse ecosystem of financial services concentrated within a specific area, bringing together many financial institutions such as banks, investment funds, financial service companies and trading platforms like securities, currency, and commodities exchanges, along with a wide range of supporting services.

Illustrative photo (Photo: VNA)

State budget collection up 24.5% in first five months

Of the sum, domestic revenue was estimated at 987.5 trillion VND, equivalent to 59.2% of the estimate and up 27.6% year-on-year, the ministry reported on June 10 at a meeting to review activities in May and implement tasks for June.

Vietnam strengthens foothold in the Canadian rice market (Photo: VNA)

Vietnam enhances rice export position in Canadian market

Amidst global trade uncertainties prompting Canada to diversify its markets, Vietnamese agricultural exporters, particularly those in the rice sector, are encouraged to seize this opportunity. Fully leveraging free trade agreements involving both countries will be key to quickly increasing Vietnam’s food exports to the North American nation.

Minister of Industry and Trade Nguyen Hong Dien has a working session with Chief Executive Officer of Warburg Pincus Investment Fund and Chairman of the US-ASEAN Business Council (USABC) Jeffrey Perlman. (Photo: VNA)

Vietnamese trade minister works with US businesses

The minister called on the USABC and the US business community continue to support Vietnam in the process of negotiating a reciprocal trade agreement with the US, and coordinate to promote the investment and business potential and opportunities in Vietnam to US partners.

Over 4 tonnes of dried red dates of unclear origin seized by authorities. (Photo: VNA)

Three-pronged approach to restore market confidence

Businesses should embrace digital technology – from blockchain to verification codes and anti-counterfeiting techniques – to build a “digital shield” that helps consumers easily identify genuine products.

An automation production system at a Viglacera Corp JSC factory in Ba Ria - Vung Tau province. (Photo: VNA)

Industrial production shows continued upward trend

Vietnam’s industrial production index (IIP) maintained strong growth momentum, rising 8.8% year-on-year in the first five months of 2025, compared to a 7.1% increase during the same period last year, according to data from the Ministry of Finance's National Statistics Office (NSO).

A Vinfast factory in Hai Phong city (Photo: VNA)

VinFast’s revenue surges nearly 150% in Q1

Aiming to double vehicle deliveries this year, VinFast is focusing on key markets including Vietnam, Indonesia, the Philippines, India, North America, and Europe, while also exploring new opportunities in the Middle East and Africa.

OSZAR »